TAILIEUCHUNG - Medical Countermeasures Dispensing Emergency Use Authorization and the Postal Model

The negative health impact of many large-scale public health emergencies, such as an intentional anthrax release, severe acute respiratory syndrome (SARS), or the recent 2009 H1N1 influenza pandemic, can be mitigated significantly by medical countermeasures such as antimicrobials, antivirals, and vaccines. To be effective, these countermeasures generally must be delivered in very large quantities in a short period of time. For example, in the event of an outdoor release of aerosolized anthrax over a wide geographic area, hundreds of thousands to millions of people would need prophylactic antibiotics within 48 hours of exposure to prevent deadly inhalational anthrax. In the event of an influenza pandemic, the timing is less urgent. | Medical Countermeasures Dispensing Emergency Use Authorization and the Postal Model Workshop Summary Clare Stroud Lori Nadig and Bruce M. Altevogt Rapporteurs Forum on Medical and Public Health Preparedness for Catastrophic Events Board on Health Sciences Policy INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES THE NATIONAL ACADEMIES PRESS Washington . THE NATIONAL ACADEMIES PRESS 500 Fifth Street . Washington DC 20001 NOTICE The project that is the subject of this report was approved by the Governing Board of the National Research Council whose members are drawn from the councils of the National Academy of Sciences the National Academy of Engineering and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by contracts between the National Academy of Sciences and the American College of Emergency Physicians the American Hospital Association the American Medical Association the American Nurses Association the Association of State and Territorial Health Officials the Centers for Disease Control and Prevention Contract No. 200-2005-13434 TO 6 the Department of Health and Human Services Agency for Healthcare Research and Quality Contract No. HHSP233200800498P the Department of Health and Human Services National Institutes of Health Contract No. N01-OD-4-2139 TO 240 the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response Contract Nos. HHSP233200900680P and HHSP23320042509X1 the Department of Homeland Security s Office of Health Affairs Contract No. HSHQDC-07-C-00097 the Department of Homeland Security Federal Emergency Management Agency Contract No. HSFEHQ-08-P-1800 the Department of the Army Contract No. W81XWH-08-P-0934 the Department of Transportation s National Highway Traffic Safety Administration DTNH22-10-H-00287 the Department of Veterans Affairs Contract .

• Y học thường thức
• Testicular Disorders
• Calcium Metabolism
• Diarrheal Diseases
• Hematologic Disorders
• Hemolytic Anemia
• Immunologic Tolerance
• Surviving Cancer
• Preventing Cancer
• Treating Cancer
• Targeted therapies
• Targeted drugs
• testicular cancer
• Error checking
• Survival analysis
• Hypothesis testing
• Bayesian methods
• MEDICAL ELECTRONIC
• Medical Devices
• BIOPOTENTIAL AMPLIFIERS
• DATA ACQUISITION
• Business Models
• Symposium Agenda